Alan Mendelsohn
Plus aucun poste en cours
Fortune : - $ au 31/03/2024
Profil
Alan Mendelsohn worked as a Senior Director in Immunology Research & Development at Johnson & Johnson from 2006 to 2014.
He then worked as a Senior Director at Pfizer Inc. from 2014 to 2016.
From 2016 to 2021, he worked as an Associate VP in Dermatology Medical Affairs at Sun Pharmaceutical Industries Ltd.
Currently, he is the Chief Medical Officer & Executive Vice President at Timber Pharmaceuticals, Inc. Dr. Mendelsohn earned a doctorate degree from the State University of New York at Downstate Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TREX WIND DOWN INC
0,00% | 07/09/2023 | 50 ( 0,00% ) | 0 $ | 31/03/2024 |
Anciens postes connus de Alan Mendelsohn
| Sociétés | Poste | Fin |
|---|---|---|
| TREX WIND-DOWN, INC. | Chief Tech/Sci/R&D Officer | 22/01/2024 |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Corporate Officer/Principal | 01/02/2021 |
| PFIZER, INC. | Director/Board Member | 01/12/2016 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01/01/2014 |
Formation de Alan Mendelsohn
| State University of New York at Downstate Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| PFIZER, INC. | Health Technology |
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| TREX WIND-DOWN, INC. | Health Technology |
